{
    "cross_check": 1,
    "version": 21,
    "phases": [
        "Pre-Clinical",
        "Phase I",
        "Phase II",
        "Phase III",
        "Approval"
    ],
    "all_phases": [
        "Pre-Clinical",
        "Phase I",
        "Phase I\/II",
        "Phase II",
        "Phase II\/III",
        "Phase III",
        "Approval",
        "Approved"
    ],
    "platforms": [
        "Live-attenuated",
        "Protein subunit",
        "Inactivated",
        "RNA",
        "Non-replicating viral vector",
        "Replicating viral vector",
        "DNA",
        "Other",
        "Unknown"
    ],
    "cepi": [
        49,
        110,
        123,
        85,
        139,
        145,
        166,
        5,
        154
    ],
    "ows": [
        166,
        150,
        49,
        39,
        110,
        115,
        138,
        51
    ],
    "platform_correlations": [
        "None",
        "Low",
        "Medium",
        "Strong"
    ],
    "funding_overlaps": {
        "simult": "Almost simultaneous",
        "mostly": "Mostly overlapped",
        "phases12": "Phases I & II overlapped",
        "phases23": "Phases II & III overlapped",
        "consec": "Consecutive",
        "gaps": "Gaps between phases"
    },
    "timeline_factors": {
        "much_faster": "Much faster",
        "faster": "Faster",
        "slightly_faster": "Slightly faster",
        "normal": "Normal",
        "slightly_slower": "Slightly slower",
        "slower": "Slower",
        "much_slower": "Much slower",
        "very_much_slower": "Very much slower"
    },
    "trials_csv_version": 1,
    "funding_categories": [
        "Large external funding",
        "Some external funding",
        "Large Pharma",
        "Medium Pharma",
        "Bio-tech\/Academic"
    ],
    "monthsTableSkip": 6,
    "rankTableMax": 10,
    "bestVaccinesMax": 10,
    "tries": 100,
    "months": 36,
    "option": "Normal",
    "pos_factor": 1.2,
    "timeline_factor": 1.2,
    "best_timeline": [
        3,
        2,
        3,
        3,
        1
    ],
    "likely_timeline": [
        6,
        4,
        5,
        9,
        3
    ],
    "worst_timeline": [
        12,
        6,
        8,
        18,
        6
    ],
    "phase_success": [
        0.66,
        0.78,
        0.66,
        0.46,
        0.74
    ],
    "platform_pos": [
        0.37,
        0.64,
        0.39,
        0.48,
        0.53,
        0.45,
        0.21,
        0.05,
        0.02
    ],
    "platform_timeline": [
        "much_slower",
        "normal",
        "faster",
        "slightly_faster",
        "slightly_slower",
        "slower",
        "slower",
        "much_slower",
        "much_slower"
    ],
    "platform_correlation": [
        "Medium",
        "Medium",
        "Medium",
        "Low",
        "Strong",
        "Strong",
        "Medium",
        "None",
        "None"
    ],
    "funding_pos": [
        1.1,
        1,
        1,
        0.95,
        0.1
    ],
    "funding_timeline": [
        "faster",
        "normal",
        "normal",
        "slower",
        "very_much_slower"
    ],
    "funding_overlap": [
        "simult",
        "mostly",
        "mostly",
        "phases23",
        "gaps"
    ],
    "funding_tech_failure": [
        1,
        1,
        1,
        0.8,
        0
    ],
    "approval_limit": 3,
    "approval_pos": 0.85,
    "approval_timeline": 1.1,
    "funding_overlap_phase_overlap": {
        "simult": 1,
        "mostly": 2,
        "phases12": 1,
        "phases23": 1,
        "consec": 0,
        "gaps": 0
    },
    "funding_overlap_phase_gap": {
        "simult": 0,
        "mostly": 0,
        "phases12": 1,
        "phases23": 1,
        "consec": 1,
        "gaps": 6
    },
    "funding_overlap_phase1_start": {
        "simult": 1,
        "mostly": 1,
        "phases12": 1,
        "phases23": 1,
        "consec": 1,
        "gaps": 1
    },
    "funding_overlap_approval_start": {
        "simult": 1,
        "mostly": 1,
        "phases12": 1,
        "phases23": 1,
        "consec": 1,
        "gaps": 1
    },
    "platform_correlation_values": {
        "None": 0,
        "Low": 0.1,
        "Medium": 0.25,
        "Strong": 0.5
    },
    "timeline_factor_values": {
        "much_faster": 0.5,
        "faster": 0.75,
        "slightly_faster": 0.9,
        "normal": 1,
        "slightly_slower": 1.1,
        "slower": 1.33,
        "much_slower": 2,
        "very_much_slower": 3
    },
    "phase3_slowdown_fract": 0.3,
    "phase3_slowdown_factor": 1.5,
    "phase3_limit": 6,
    "phase3_action": "Slow Down",
    "phase3_limit_factor": 1.5,
    "bio_buyout_fract": 1,
    "do_update_pos": 1,
    "do_update_approval": 1,
    "do_limit_phase3": 1,
    "do_buyout_bio": 1,
    "do_ignore_future_dates": 1,
    "do_manufacturing": 1,
    "manufacturing": {
        "Doses needed": {
            "Group 1": 0.05,
            "Group 2": 0.65,
            "Group 3": 1.15,
            "Group 4": 6.15,
            "Percentage of drug wastage": 15,
            "Number of doses per vaccine": 2
        },
        "Gantt Timelines": {
            "All Platform": {
                "Low": 7,
                "Most Likely": 11,
                "High": 16
            },
            "Live-attenuated": {
                "Low": 10,
                "Most Likely": 16,
                "High": 34
            },
            "Protein subunit": {
                "Low": 10,
                "Most Likely": 16,
                "High": 34
            },
            "Inactivated": {
                "Low": 10,
                "Most Likely": 16,
                "High": 34
            },
            "RNA": {
                "Low": 10,
                "Most Likely": 16,
                "High": 54
            },
            "Non-replicating viral vector": {
                "Low": 10,
                "Most Likely": 16,
                "High": 42
            },
            "Replicating viral vector": {
                "Low": 10,
                "Most Likely": 16,
                "High": 42
            },
            "DNA": {
                "Low": 10,
                "Most Likely": 16,
                "High": 42
            },
            "Other": {
                "Low": 10,
                "Most Likely": 16,
                "High": 42
            }
        },
        "Pri Input": {
            "Live-attenuated": {
                "Lowest Volume V (m3)": 701,
                "Most Likely Volume V (m3)": 779,
                "Highest Volume V (m3)": 856,
                "Doses per litre of bioreactor volume (N_dv)": 4000,
                "Batches per year (B)": 25,
                "Doses for most likely volume (Million Doses per month) N_v": 6491.666666666667
            },
            "Protein subunit": {
                "Lowest Volume V (m3)": 1002,
                "Most Likely Volume V (m3)": 1113,
                "Highest Volume V (m3)": 1225,
                "Doses per litre of bioreactor volume (N_dv)": 2500,
                "Batches per year (B)": 25,
                "Doses for most likely volume (Million Doses per month) N_v": 5796.875
            },
            "Inactivated": {
                "Lowest Volume V (m3)": 701,
                "Most Likely Volume V (m3)": 779,
                "Highest Volume V (m3)": 856,
                "Doses per litre of bioreactor volume (N_dv)": 4000,
                "Batches per year (B)": 25,
                "Doses for most likely volume (Million Doses per month) N_v": 6491.666666666667
            },
            "RNA": {
                "Lowest Volume V (m3)": 150955,
                "Most Likely Volume V (m3)": 167728,
                "Highest Volume V (m3)": 184501,
                "Doses per litre of bioreactor volume (N_dv)": 50,
                "Batches per year (B)": 0,
                "Doses for most likely volume (Million Doses per month) N_v": 279.5466666666667
            },
            "Non-replicating viral vector": {
                "Lowest Volume V (m3)": 1002,
                "Most Likely Volume V (m3)": 1113,
                "Highest Volume V (m3)": 1225,
                "Doses per litre of bioreactor volume (N_dv)": 5000,
                "Batches per year (B)": 25,
                "Doses for most likely volume (Million Doses per month) N_v": 11593.75
            },
            "Replicating viral vector": {
                "Lowest Volume V (m3)": 1002,
                "Most Likely Volume V (m3)": 1113,
                "Highest Volume V (m3)": 1225,
                "Doses per litre of bioreactor volume (N_dv)": 5000,
                "Batches per year (B)": 25,
                "Doses for most likely volume (Million Doses per month) N_v": 11593.75
            },
            "DNA": {
                "Lowest Volume V (m3)": 241,
                "Most Likely Volume V (m3)": 268,
                "Highest Volume V (m3)": 295,
                "Doses per litre of bioreactor volume (N_dv)": 200,
                "Batches per year (B)": 25,
                "Doses for most likely volume (Million Doses per month) N_v": 111.66666666666667
            },
            "Other": {
                "Lowest Volume V (m3)": 1002,
                "Most Likely Volume V (m3)": 1113,
                "Highest Volume V (m3)": 1225,
                "Doses per litre of bioreactor volume (N_dv)": 2740,
                "Batches per year (B)": 25,
                "Doses for most likely volume (Million Doses per month) N_v": 6353.375000000001
            }
        },
        "Timelines by funding criteria": {
            "Large external funding": {
                "Gantt duration factor*": 1,
                "Simultaneous tech transfer?": 1,
                "Manufacturing start before approval?": 1
            },
            "Some external funding": {
                "Gantt duration factor*": 1,
                "Simultaneous tech transfer?": 1,
                "Manufacturing start before approval?": 1
            },
            "Large Pharma": {
                "Gantt duration factor*": 1,
                "Simultaneous tech transfer?": 1,
                "Manufacturing start before approval?": 1
            },
            "Medium Pharma": {
                "Gantt duration factor*": 1,
                "Simultaneous tech transfer?": 1,
                "Manufacturing start before approval?": 0
            },
            "Bio-tech\/Academic": {
                "Gantt duration factor*": 1,
                "Simultaneous tech transfer?": 1,
                "Manufacturing start before approval?": 0
            }
        },
        "Sec Input": {
            "Lowest Available Capacity (million doses\/month)": 1061,
            "Most Likely Available Capacity (million doses\/month)": 1327,
            "Highest Available Capacity (million doses\/month)": 4268
        }
    }
}